Patents Assigned to Pierre Babre Medicament
  • Antibodies inhibiting c-Met dimerization, and uses thereof
    Patent number: 8871910
    Abstract: The present inventions relates to a process for the selection of anti c-Met antibodies capable to inhibit both ligand-dependent and ligand-independent activation of c-Met. More particularly, said process is based on the inhibition of the c-Met dimerization. In another aspect, the present invention concerns such antibodies and compositions comprising such antibodies for the preparation of a medicament to treat cancer. Diagnosis process and kits are also part of the invention.
    Type: Grant
    Filed: November 9, 2012
    Date of Patent: October 28, 2014
    Assignee: Pierre Babre Medicament
    Inventor: Liliane Goetsch